The Budding Yeast “Saccharomyces cerevisiae” as a Drug Discovery Tool to Identify Plant-Derived Natural Products with Anti-Proliferative Properties
2011

Using Yeast to Find New Cancer Treatments from Plants

Sample size: 62 publication Evidence: moderate

Author Information

Author(s): Qaddouri Bouchra, Guaadaoui Abdelkarim, Bellirou Ahmed, Hamal Abdellah, Melhaoui Ahmed, Brown Grant W., Bellaoui Mohammed

Primary Institution: Université Mohamed Premier

Hypothesis

Can the budding yeast Saccharomyces cerevisiae be used to identify plant-derived natural products with anti-proliferative properties?

Conclusion

The study found that the plant-derived compound Lyc disrupts cell-cycle progression in yeast, indicating its potential as a candidate for cancer treatment.

Supporting Evidence

  • The study identified 14 plant extracts and 8 natural molecules with growth-inhibitory effects.
  • Lyc treatment resulted in a significantly reduced growth rate of yeast cells.
  • Cell-cycle analysis showed that Lyc caused abnormal DNA content in yeast cells.
  • Morphological alterations were observed in yeast cells treated with Lyc.

Takeaway

Scientists used yeast to test plant extracts and found one that stops yeast from growing, which might help in finding new cancer medicines.

Methodology

The study involved screening a library of plant-derived natural products in yeast to identify compounds with anti-proliferative properties.

Limitations

The study primarily focuses on yeast models, which may not fully replicate human responses.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1093/ecam/nep069

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication